The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1111/iej.13647
|View full text |Cite
|
Sign up to set email alerts
|

A critical analysis of research methods to study clinical molecular biomarkers in Endodontic research

Abstract: The term biomarker has been defined as a characteristic that is objectively measured and evaluated as an indicator of normal biological and pathogenic processes, or pharmacologic responses to a therapeutic intervention (Atkinson & Colburn, 2001). The term is mainly used to describe a molecule collected from a biological fluid that is correlated to a specific condition, development of a condition or identification of the same. Hence, any type of study that identifies and correlates molecules from endodontic sam… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 74 publications
1
11
0
1
Order By: Relevance
“…Unfortunately, there is a lack of objective diagnostic tools in VPT with the reference standard, histological assessment, of no value for patients as it necessitates tooth extraction (Duncan, 2022). The development of objective, robust inflammatory (Ballal et al, 2021) or other biomarkers (Al‐Natour et al, 2021; Kearney et al, 2018; Rechenberg et al, 2016), which accurately reflect not only the level of inflammation in the pulp but also identifies the threshold between reversible and irreversible pulpitis, have long been considered a priority in endodontics (Zehnder & Belibasakis, 2022). In an ideal world, a small sample of pulpal blood, or another suitable analyte (dentinal fluid, gingival crevicular fluid), could be analysed in real time at chairside with a lateral flow antibody test and the results used to dictate tissue removal and subsequent treatment.…”
Section: Reviewmentioning
confidence: 99%
“…Unfortunately, there is a lack of objective diagnostic tools in VPT with the reference standard, histological assessment, of no value for patients as it necessitates tooth extraction (Duncan, 2022). The development of objective, robust inflammatory (Ballal et al, 2021) or other biomarkers (Al‐Natour et al, 2021; Kearney et al, 2018; Rechenberg et al, 2016), which accurately reflect not only the level of inflammation in the pulp but also identifies the threshold between reversible and irreversible pulpitis, have long been considered a priority in endodontics (Zehnder & Belibasakis, 2022). In an ideal world, a small sample of pulpal blood, or another suitable analyte (dentinal fluid, gingival crevicular fluid), could be analysed in real time at chairside with a lateral flow antibody test and the results used to dictate tissue removal and subsequent treatment.…”
Section: Reviewmentioning
confidence: 99%
“…This generally requires exposure of the pulp; however, as the volume of analyte retrieved from dentinal fluid in unexposed cavities is likely to be too small for robust analysis (Rechenberg et al, 2016 ; Zehnder et al, 2011 ). Furthermore, although attractive, biomarker analysis from pulpal blood is fraught with technical, practical and scientific challenges, which have been extensively reviewed elsewhere in this series (Zehnder & Belibasakis, 2021 ).…”
Section: Reviewmentioning
confidence: 99%
“…We may hope that, in the not too distant future, user-friendly and accurate chairside methods for pulpal and periapical diagnosis may become generally available (19). However, extensive, and time-consuming translational research will be necessary to apply new knowledge from sterile laboratory studies to the development of reliable clinical methods for chair-side patient diagnosis.…”
Section: • 133 • #2 125mentioning
confidence: 99%